LEADER 01247nas 22004453a 450 001 996218777203316 005 20220226213023.0 011 $a1522-9025 035 $a(DE-599)ZDB2219022-3 035 $a(OCoLC)40477156 035 $a(CKB)110975506072261 035 $a(CONSER)sn-98005064- 035 $a(EXLCZ)99110975506072261 100 $a19981211b19992010 --- a 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aJournal of new seeds 210 $a[Binghamton, NY] $cThe Haworth Press$d©1999-©2010 210 3 $a[Philadelphia, PA] $cTaylor & Francis Inc 300 $aRefereed/Peer-reviewed 311 $a1522-886X 531 $aJ NEW SEEDS 531 0 $aJ. new seeds 606 $aSeeds$vPeriodicals 606 $aSeed technology$vPeriodicals 606 $aSeed technology$2fast$3(OCoLC)fst01111086 606 $aSeeds$2fast$3(OCoLC)fst01111109 608 $aPeriodicals.$2fast 615 0$aSeeds 615 0$aSeed technology 615 7$aSeed technology. 615 7$aSeeds. 676 $a631 906 $aJOURNAL 912 $a996218777203316 996 $aJournal of new seeds$92355412 997 $aUNISA LEADER 05842nam 2200565 450 001 996339098403316 005 20230721043730.0 010 $a1-61711-672-6 035 $a(CKB)3780000000079876 035 $a(EBL)3404688 035 $a(OCoLC)919499457 035 $a(SSID)ssj0001059559 035 $a(PQKBManifestationID)11558486 035 $a(PQKBTitleCode)TC0001059559 035 $a(PQKBWorkID)11081360 035 $a(PQKB)11713525 035 $a(MiAaPQ)EBC3404688 035 $a(EXLCZ)993780000000079876 100 $a20080131h20082008 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCurbside consultation in glaucoma $e49 clinical questions /$feditor, Dale K. Heuer ; associate editors, Steven J. Gedde, Richard A. Lewis 210 1$aThorofare, New Jersey :$cSLACK,$d[2008] 210 4$d©2008 215 $a1 online resource (260 p.) 225 1 $aCurbside consultation in ophthalmology 300 $aDescription based upon print version of record. 311 $a1-55642-832-4 320 $aIncludes bibliographical references. 327 $aHow frequently does blindness develop among patients with primary open-angle glaucoma? With ocular hypertension -- Does reducing intraocular pressure really prevent development and progression of glaucoma -- What are the most frequent causes of glaucoma-related medical malpractice suits? What can I do to minimize my risk? -- How should I clinically examine the optic nerve -- What imaging device should I use in my practice -- Is there still a role for stereo disc photography in the diagnosis and management of glaucoma -- What visual field tests should I use in my glaucoma suspects? In my patients with manifest glaucoma? -- What is the best method for detecting glaucoma development? Glaucomatous progression? -- What are the implications of disc hemorrhages in glaucoma patients or suspects? How should I follow patients with anomalous optic discs, such as those with optic nerve drusen, tilted discs, myopic discs, and discs with pits? -- How is 24-hour intraocular pressure assessed? Is it important in glaucoma management or risk assessment? -- Should I measure central corneal thickness in all glaucoma patients? All glaucoma suspects? How frequently should I perform follow-up examinations, gonioscopy, visual field testing, and optic nerve evaluation in glaucoma patients? -- In which patients with glaucoma should I perform neuroimaging, cardiovascular evaluation, and/or laboratory testing? When should I suspect nonpupillary block secondary angle-closure? What are the causes? What systemic diseases can be associated with glaucoma? 327 $aWhich patients with ocular hypertension should I treat? -- How should I set a target intraocular pressure? -- How should I begin treatment for a newly diagnosed primary open-angle glaucoma patient? -- Are there special issues of which I should be aware regarding pigment dispersion syndrome or pigmentary glaucoma? -- Does exfoliation syndrome increase the risk of developing glaucoma? Are patients with exfoliation glaucoma more likely to progress? What other issues do these patients have? -- How frequent is corticosteroid-induced glaucoma? How should I manage it? -- What methods are available to break an acute attack of angle-closure glaucoma? -- How should I manage neovascular glaucoma? -- How should I treat elevated intraocular pressure (with or without glaucoma damage) associated with uveitis? -- What treatment options are available for a blind, painful eye? 327 $aIs a unilateral trial useful when starting treatment with a glaucoma medication? -- Which glaucoma medications should be used as initial therapy? -- What is a maximum medical therapy in glaucoma management? -- Which glaucoma medications can be safely used during pregnancy? In childhood? -- Is there still a role for miotics in some patients? Oral carbonic anhydrase inhibitors? -- How should I treat the glaucoma patient with topical drug allergies? -- How can I improve patient adherence? 327 $aWhen should I perform laser trabeculoplasty in my patients with open-angle glaucoma? -- When should I perform a prophylactic laser iridotomy? -- When is laser iridotomy used? -- When is incisional glaucoma surgery indicated? -- What can I do to reduce the risks of complications and failure after trabeculectomy? -- What can I do after trabeculectomy to improve its success rate? -- How do I manage chronic hypotony maculopathy? How soon should I intervene? - What are causes of anterior chamber shallowing after trabeculectomy? -- How should I manage a late-onset bleb leak? -- What factors increase the risk of bleb-related infection? How should I treat blebitis and bleb-related endophthalmitis if it develops? -- In which patients with glaucoma and cataracts should I perform a combined procedure? Cataract surgery alone? Trabeculectomy first? -- What are the indications for placement of an aqueous shunt? -- What is the best surgical approach for managing uncontrolled glaucoma in a patient who had previous cataract extraction or failed filtering surgery? -- Is there a role for nonpenetrating glaucoma surgery? -- What other new surgical techniques are available for glaucoma? -- In which glaucoma patients should I consider cyclodestruction? 410 0$aCurbside consultation in ophthalmology series. 606 $aGlaucoma$vMiscellanea 615 0$aGlaucoma 676 $a617.7/41 701 $aHeuer$b Dale K$01019079 701 $aGedde$b Steven J$01019080 701 $aLewis$b Richard A.$f1951-$01019081 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996339098403316 996 $aCurbside consultation in glaucoma$92400572 997 $aUNISA LEADER 02347nam 2200553 450 001 9910818226003321 005 20230803202554.0 010 $a1-78023-319-1 035 $a(CKB)3710000000115304 035 $a(EBL)1693645 035 $a(SSID)ssj0001253881 035 $a(PQKBManifestationID)11707602 035 $a(PQKBTitleCode)TC0001253881 035 $a(PQKBWorkID)11216000 035 $a(PQKB)11703595 035 $a(MiAaPQ)EBC1693645 035 $a(Au-PeEL)EBL1693645 035 $a(CaPaEBR)ebr10875746 035 $a(CaONFJC)MIL615160 035 $a(OCoLC)880531534 035 $a(EXLCZ)993710000000115304 100 $a20140611h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe luminous and the grey /$fDavid Batchelor 210 1$aLondon, England :$cReaktion Books,$d2014. 210 4$d©2014 215 $a1 online resource (113 p.) 300 $aDescription based upon print version of record. 311 $a1-78023-280-2 320 $aIncludes bibliographical references. 327 $aCover; The Luminous and the Grey; Imprint Page; Contents; Preface; One: The Beginning and the End of Colour; Two: The Luminous and the Grey; Three: The Grey and the Luminous; References; Bibliography; Acknowledgements; List of Illustrations 330 $aColor surrounds us: the lush green hues of trees and grasses, the variant blues of water and the sky, the bright pops of yellow and red from flowers. But at the same time, color lies at the limits of language and understanding. In this absorbing sequel to Chromophobia-which addresses the extremes of love and loathing provoked by color since antiquity-David Batchelor charts color's more ambiguous terrain. The Luminous and the Grey explores the places where color comes into being and where it fades away, probing when it begins and when it ends both in the imagination a 606 $aColor$xPsychological aspects 606 $aColor in art 615 0$aColor$xPsychological aspects. 615 0$aColor in art. 676 $a155.91145 700 $aBatchelor$b David$01698909 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910818226003321 996 $aThe luminous and the grey$94080750 997 $aUNINA LEADER 03269nam 22007335 450 001 9910254670403321 005 20251030105609.0 010 $a9781137577276 010 $a1137577274 024 7 $a10.1057/978-1-137-57727-6 035 $a(CKB)3710000000666602 035 $a(DE-He213)978-1-137-57727-6 035 $a(MiAaPQ)EBC4720274 035 $a(PPN)222239980 035 $a(Perlego)3483059 035 $a(EXLCZ)993710000000666602 100 $a20160509d2016 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBlack Swan Start-ups $eUnderstanding the Rise of Successful Technology Business in Unlikely Places /$fby Sami Mahroum 205 $a1st ed. 2016. 210 1$aLondon :$cPalgrave Macmillan UK :$cImprint: Palgrave Macmillan,$d2016. 215 $a1 online resource (XXIII, 254 p. 3 illus. in color.) 300 $aIncludes index. 311 08$a9781137577269 311 08$a1137577266 330 $aThis book explores startups that have thrived against the odds in places where startup success was deemed to be unlikely. Discussing a number of technology startups from around the world that have succeeded without state backing nor local venture and seed capital, Black Swan Start Ups provides unique insights into unsung models of success beyond the two dominant narratives of Asia?s ?Tiger Economies? and America?s Silicon Valley miracle. The author describes these stories of success as ?black swan events? and ascribes their achievements to the ability of entrepreneurs to leverage the ?place surplus? of their locations, while building connections to support networks outside their immediate geographies. Including case studies such as Skype in Estonia, SoundCloud in Germany and Bayt.Com in Dubai, this insightful book gives a holistic and wide-ranging view of how technology startups have, and can, succeed in less likely places. . 606 $aNew business enterprises 606 $aVenture capital 606 $aSmall business 606 $aIndustrial organization 606 $aTelemarketing 606 $aInternet marketing 606 $aTechnological innovations 606 $aBusiness information services 606 $aStart-Ups and Venture Capital 606 $aSmall Business 606 $aOrganization 606 $aDigital Marketing 606 $aInnovation and Technology Management 606 $aIT in Business 615 0$aNew business enterprises. 615 0$aVenture capital. 615 0$aSmall business. 615 0$aIndustrial organization. 615 0$aTelemarketing. 615 0$aInternet marketing. 615 0$aTechnological innovations. 615 0$aBusiness information services. 615 14$aStart-Ups and Venture Capital. 615 24$aSmall Business. 615 24$aOrganization. 615 24$aDigital Marketing. 615 24$aInnovation and Technology Management. 615 24$aIT in Business. 676 $a658.421 700 $aMahroum$b Sami$4aut$4http://id.loc.gov/vocabulary/relators/aut$0954559 906 $aBOOK 912 $a9910254670403321 996 $aBlack Swan Start-ups$92159174 997 $aUNINA